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Abstract
Background: Subtelomeric regions are gene rich and deletions in these chromosomal segments
have been demonstrated to account for approximately 2.5% of patients displaying mental
retardation with or without association of dysmorphic features. However, cases that report de
novo terminal deletions on chromosome arm 15q are rare.
Methods: In this study we present the first example of a detailed molecular genetic mapping of a
de novo deletion in involving 15q26.2-qter, caused by the formation of a dicentric chromosome 15,
using metaphase FISH and tiling resolution (32 k) genome-wide array-based comparative genomic
hybridization (CGH).
Results: After an initial characterization of the dicentric chromosome by metaphase FISH, array
CGH analysis mapped the terminal deletion to encompass a 6.48 megabase (Mb) region, ranging
from 93.86–100.34 Mb on chromosome 15.
Conclusion: In conclusion, we present an additional case to the growing family of reported cases
with 15q26-deletion, thoroughly characterized at the molecular cytogenetic level. In the deleted
regions, four candidate genes responsible for the phenotype of the patient could be delineated:
IGFR1, MEF2A, CHSY1, and TM2D3. Further characterization of additional patients harboring similar
15q-aberrations might hopefully in the future lead to the description of a clear cut clinically
recognizable syndrome.
Background
The subtelomeric regions of chromosomes are particularly
gene rich [1] and deletions in these regions have been
demonstrated to account for approximately 2.5% of
patients displaying mental retardation with/without asso-
ciation of dysmorphic features [2]. The small interstitial
deletion on the long arm of chromosome 15 causing
Prader-Willi/Angelman (P-W/A) syndrome is well docu-
mented [3] whereas cases that report de novo terminal
deletions on 15q are rare. Excluding cases displaying vari-
ous ring structures that result in different sized deletions
of chromosome 15 or unbalanced reciprocal transloca-
tions involving distal parts of 15q, only 12 cases have
been reported harboring pure distal 15q26 deletions [4-
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including intrauterine growth retardation, complex car-
diac abnormalities, developmental delay, clinodactyly,
ear abnormalities, lung hypoplasia, microcephaly, dia-
phragmatic hernia, high arched palate, and hypoplastic
kidneys. Reported survival of patients varied from 20 min-
utes to 12 years [12].
Previous mapping studies have by means of fluorescent in
situ hybridization (FISH) demonstrated that terminal
15q-deletion frequently results in loss of one IGF1R allele.
It has been postulated that a dosage effect of the IGF1R
gene might be direct responsible for the intrauterine
growth retardation seen in patients monosomic for 15q26
and for the postnatal overgrowth seen in patients trisomic
for 15q25-qter [15]. However in vitro studies on fibrob-
last cells have been ambiguous. For instance Siebler et al.
(1999) failed to provide conclusive evidence for a biolog-
ical response to lowered IGFR1 expression due to distal
deletion of 15q whereas Okubo et al. demonstrated accel-
erated and decreased growth in cells with three or one
copy of the gene, respectively [5,8].
In this report we present a detailed genetic mapping
including classical cytogenetics, metaphase FISH and til-
ing resolution (32 k) genome-wide array-based compara-
tive genomic hybridization (array CGH) of a patient with
a de novo deletion of subband 15q26.2, caused by the for-
mation of a dicentric chromosome 15. Only one similar
case with a karyotype harboring a bisatellite dicentric
chromosome, resulting in a distal 15q deletion, has been
reported previously in the literature [6].
Case Report
The patient is the first child to healthy parents (maternal
age 29 years) and was born at the 37th week of pregnancy.
APGAR score was 8-9-9. The birth-weight was 2.4 kg, bor-
derline to small for gestational age. Single umbilical artery
was not present. Growth and height centiles were ≤3 for
the patient both at 1, 18 and 22 months of age. The child
was first examined in the 33rd gestational week, when fetal
screening had indicated abnormal heart size. Fetal
echocardiography showed a clearly enlarged right ventri-
cle and a narrow left ventricle with a slightly small mitral
valve. There was suspicion of a ventricular septal defect
(VSD). The aortic arch could not be completely eluci-
dated. A magnetic resonance tomography (MRT) was
made of the fetus, but no further information was
obtained. Neonatal echocardiography confirmed a large
right ventricle, a somewhat underdeveloped left side, and
gave a strong suspicion of coarctation of the aorta. There
was also a small VSD. Treatment with prostaglandin was
started and the child was put on ventilator. MRT showed
a coarctation and an abnormal aortic arch with a very
acute angle between the ascending and the descending
aorta. The child was operated at the age of three days with
resection of the coarctation and end-to-side anastomosis.
The postoperative period was uneventful except for bouts
of supraventricular tachycardia that were treated with ade-
nosine and digitalis. X-ray showed relaxation of the right
side of the diaphragm. Because of the patient's unusual
facial features with low set ears, small chin, and haeman-
gioma on the forehead, a chromosome analysis was per-
formed on a blood sample drawn at day five.
At the age of 18 months the child is small with a weight of
7,7 kg and a length of 70 cm. The patient's physical and
mental developmental milestones are severely delayed.
He has been operated with a percutaneous gastrostomy
and takes hardly any food by mouth, harboring problems
with vomiting and gastrooesophageal reflux. At the lastest
follow up the patients cardiac status was fairly good, indi-
cating favorable result of the coarctation operation, but
displayed signs of a moderate mitral stenosis and a
remaining small VSD. He displays dysmorphic features
like hypertelorism, rocker bottom feet, broad nasal
bridge, narrow upper lip and flat philtrum (Figure 1).
PatientFigure 1
Patient. Phenotypic characteristics of the patient at 20 
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Blood samples from the patient and his parents were
drawn after informed consent. Lymphocyte culture upon
phytohemagglutinin stimulation and G-banding analysis
was performed in standard clinical settings on the three
samples. Both parents displayed normal karyotypes.
An initial analysis of the derivative chromosome detected
in the patient was conducted with a whole chromosome
paint (WCP) probe and a centromere probe specific for
chromosome 15 (Vysis, Downers Grove, US) as well as
with a probe specific for the nucleolus organizing regions
(NOR) of the acrocentric chromosomes (Chrombios,
Raubling, Germany). A probe specific for the P-W/A
region (LSI D15S10/CEP15/LSI PML; Vysis) was also
used. For a refined analysis of the derivative chromosome,
a total of 12 bacterial artificial chromosome (BAC) probes
targeting the 15q11.2-q14 region and the 15q25.1-q26.3
region, were selected from the UCSC Genome Browser
[16] (Table 1). BAC DNA was extracted by alkaline lysis
with SDS using standard protocols and labeled with Cy3-
dUTP (GE Healthcare Bio-Sciences Corporation, Piscata-
way, NJ) or Fluorescein-12-dUTP (FITC) (Roche, Man-
nheim, Germany) using the Megaprime DNA Labelling
System (GE Healthcare Bio-Sciences Corporation). Fixed
metaphase spreads were aged over night at 60°C then pre-
treated with 20 mg/ml pepsin (Serva, Heidelberg, Ger-
many), postfixed in 1% formaldehyde and finally
dehydrated in an ethanol series (70%, 85%, 100%). Com-
mercial probes were hybridized according to the manufac-
turers' recommendations. For each BAC probe, a total of
90 ng labeled DNA was hybridized. After application of
the probe solution and sealing of the metaphase spread,
the preparations were denaturated on a hot plate for 4
min at 74°C and then incubated over-night in a humid
chamber at 37°C. Post-hybridization washes were done
in 0.4× SSC/0.05% Tween-20 (Sigma-Aldrich, St Louis,
US) followed by dehydration in an ethanol series. For
detection of the nuclei and evaluation of the fluorescent
signals, the spreads were counterstained with 0.5 mg/ml
4,6-diamidino-2-phenylindole (DAPI; Sigma-Aldrich)
and mounted in a 2% 1,4-diazabicyclo-[2,2,2]-octane
(DABCO) solution (Sigma-Aldrich). Conventional epiflu-
orescence microscopy was carried out with a Zeiss
Axioplan2 imaging microscope (Zeiss, Jena, Germany)
linked to a CytoVision Ultra system (Applied Imaging,
San José, US). A minimum of 11 metaphases (median 17)
were analyzed for each probe mixture.
DNA was extracted from the peripheral blood cells
obtained at the time of diagnosis. Male genomic DNA
(Promega, Madison, WI) was used as reference in the
hybridization. The 32 k slides used, containing 32 433 til-
ing BAC clones covering at least 98% of the human
genome, were produced at the SWEGENE DNA microar-
ray resource center at Lund University, Sweden. Labeling
of DNA, slide preparation, and hybridization were per-
formed as described [17] with minor modifications. Anal-
ysis of the microarray images were performed with the
GenePix Pro 4.0 software (Axon Instruments, Foster City,
CA). For each spot, the median pixel intensity minus the
median local background for both dyes was used to
obtain the ratio of test gene copy number to reference
gene copy number. Data normalization was performed
for each array subgrid using lowess curve fitting with a
smoothing factor of 0.33 [18]. The sex chromosomes were
excluded when calculating the correction factor in the nor-
malization of the data set. All normalizations and analy-
Table 1: Information on the probes used and results of hybridizations
Probe information Results of FISH analyses
Probe name Accession no. Locus Normal 15 dic(15;15)
NOR - p-arm* 1 signal 2 signals
CEP15 - 15p11.1-q11.1 1 signal 2 signals
RP11-509A17 AC026495 15q11.2 1 signal 1 signal
RP11-228M15 AC091565 15q11.2 1 signal 1 signal
RP11-1071C22 AQ813791, AQ791136 15q11.2 SNRPN 1 signal 1 signal
RP11-89E18 AQ282759, AQ282775 15q12 1 signal 1 signal
RP11-165M18 AQ382104, AQ382108 15q13.1 1 signal 1 signal
RP11-303I17 AZ301277, AZ301278 15q13.2-13.3 1 signal 1 signal
RP11-194H7 AQ412869 15q14 1 signal 1 signal
RP11-91M4 AQ282682, AQ282685 15q25.1 1 signal 1 signal
RP11-90B9 AZ517977, AQ283516 15q25.2 1 signal 1 signal
RP11-60P2 AC105120 15q25.3 1 signal 1 signal
RP11-378B5 AZ301319, AZ301320 15q26.1 1 signal 1 signal
RP11-79C10 AZ519147, AQ581275 15q26.2 1 signal No signal
RP11-90E5 AQ281493, AQ281496 15q26.3 1 signal No signal
*The NOR probe hybridizes to the p-arm of all acrocentric chromosomes (13, 14, 15, 21, 22)Page 3 of 8
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database (BASE) [19]. To identify imbalances, the MAT-
LAB toolbox CGH plotter and the TM4 software suite [20]
was applied, using a moving mean average over three
clones and log2 limits of ≥0.2. Classification as gain or
loss was based on identification as such by the CGH plot-
ter and also by visual inspection of the log2 ratios. Ratios
+/- ≥0.5 in three adjacent clones were classified as abnor-
mal, with ratios between 0.5 and 1.0 interpreted as dupli-
cations/hemizygous deletions and ≥1.0 classified as
amplifications/homozygous deletions.




Cytogenetic studies from the peripheral blood of the two-
months-old patient displayed a male karyotype with a
dicentric chromosome 15:
46,XY,+15,dic(15;15)(q11;q26.1) (Figure 2). Maternal
and paternal karyotypes were normal. The characteriza-
tion of the derivative chromosome was expanded by FISH
in order to elucidate the cytogenetic findings. The subse-
quent array CGH analysis was performed at a later stage
after informed consent from the patients' parents.
FISH
Hybridization with chromosome 15 specific WCP- and
centromere probes indicated that the derivative chromo-
some was composed entirely of material from chromo-
some 15 and that it contained two centromeric regions,
one at each end of the structure (Figure 3a). Hybridization
with a NOR-specific probe showed a bright signal at each
end of the structure implying the presence of p-arm mate-
rial in duplicate on the derivative chromosome. The con-
trol probe RP11-194H7, hybridizing to15q14, was
present only in one copy on the derivative chromosome
(Figure 3b). Hybridization with the probe specific for the
P-W/A locus was not conclusive (data not shown) but
hybridization with the BAC probe RP11-1071C22
showed that SNRPN gene was not deleted indicating that
P-W/A was not a putative diagnosis. Hybridization with
additional 12 BAC probes revealed a normal hybridiza-
tion pattern for the probes specific for the 15q11.2-q13.2
and 15q25.1-q26.1 regions, implicating that the corre-
sponding chromosomal material was present only in one
copy on the derivative chromosome. Hybridization with
the BAC probes RP11-79C10 and RP11-90E5, specific for
regions within 15q26.2 and 15q26.3, respectively,
showed signals only on the normal chromosome 15
homologue implicating a lack of these regions on the
derivative chromosome (Figure 3c). The results of the
FISH analysis are summarized in Table 1.
Array CGH
The array CGH analysis confirmed the distal deletion of
15q resulting from the dic(15) that was initially detected
by the G-banding analysis. In concordance with the sub-
sequent FISH findings the deletion breakpoint was revised
to 15q26.2 instead of 15q26.1 (Figure 4), the breakpoint
most frequently reported in the literature for similar cases
and also diagnosed by our clinical cytogeneticists in the
initial G-banding analysis (Figure 2). The array CGH anal-
ysis mapped the terminal deletion to encompass a 6.48
megabase (Mb) region, ranging from 93.86–100.34 Mb
on chromosome 15. Known genes in the region are sum-
marized in Table 2. No additional aberrations were
detected.
Discussion
Constitutional deletions involving chromosome band
15q26 seem to be rather rare unbalanced aberrations
which seldom are diagnosed and characterized at the
cytogenetic level. However with subtelomeric FISH
becoming standard clinical practice and array CGH being
more commonly implicated as a powerful tool to charac-
terize cases with submicroscopic aberrations it is likely to
assume that patients harboring distal 15q-deletions might
be more frequently discovered in the future.
In this study we used array CGH to delineate the break-
point to position 93.86 Mb on chromosome 15. This was
consistent with the preceding FISH analysis that localized
the most proximally deleted BAC as clone RP11-79C10,
positioned within subband 15q26.2, and encompassing
the area detected by array CGH [21]. This approach of
using tiling BACs to cover the whole genome in a single
hybridization gives a resolution standard of 150–350 kb,
applying the exclusion criteria that three contiguous
clones must display abnormal log2 ratios to be considered
to signal an aberration. This study, characterizing in detail
CytogeneticsFigur  2
Cytogenetics. Representative karyogram of the patient dis-
playing the detected dic(15) and normal 15 from two differ-
ent karyotypes.Page 4 of 8
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using molecular cytogenetic characterization with sub-
megabase resolution on a syndrome related to this chro-
mosomal region. Klaassens et al. (2005) used a similar
approach relying on array CGH and FISH, but focused on
cases presenting with distal 15q breakpoints resulting
from ring chromosome formation or unbalanced translo-
cations to determine a critical region associated with con-
genital diaphragmatic hernia (CDH). The platform used
was a 1-Mb Human BAC array, giving resolution stand-
ards tenfold smaller than 32 k arrays [11]. However, a
later study used array techniques with submegabase reso-
lution on a similar patient [22]. In addition Slavotinek et
al. (2005) have previously identified microdeletions at
15q26.2 to be associated with Fryns syndrome, a CDH-
related autosomal recessive syndrome with relatively
homogenous phenotype, using 2.4 k array [14].
The origin of the dicentric chromosome in the present
case remains unknown since both parents displayed nor-
mal karyotypes and directed microsatellite analysis was
not performed. However, it has been demonstrated that a
de novo 15q-deletion can be of both paternal and mater-
nal origin [4,6]. Studies on terminal chromosomal dele-
tions have suggested that de novo telomere addition, by
telomerase activity or recombinant mechanisms, work to
stabilize the affected chromosome [23]. It could be specu-
lated that the latter event might explain the formation of
the dic(15) in the present case, but involving centromeres
rather than telomeres. It is noteworthy that no duplica-
tion of near-centromeric q-arm material could be detected
on the log2 ratio plot of chromosome 15 (Figure 4). The
preceding FISH analysis had confirmed that the duplica-
tion included the centromeric region, as well as p-arm
material, both being located in regions not covered by the
array.
The vast majority of patients with deletions of distal 15q
have displayed pre- and postnatal growth retardation, car-
diac defects, developmental delay, ear abnormalities, and
clinodactyly. A variety of other different dysmorphic fea-
tures have however been reported in association with
Illustrative metaphase FISH imagesFigu e 3
Illustrative metaphase FISH images. The derivative chromosome is indicated with an arrow. A. Hybridization with a 
chromosome 15 specific WCP probe and a centromere 15 (CEP15) specific probe indicating that the derivative chromosome 
was entirely composed of chromosome 15-material and that it was dicentric. WCP15 cross-hybridizes with the p-arms of all 
acrocentric chromosomes (seen as green spots). B. Hybridization with a probe specific for the nucleolus organizing regions 
(NOR) of the acrocentric chromosomes and a control probe (15q14) showing the presence of p-arm material in duplicate on 
the derivative chromosome. C. Hybridization with BAC probes specific for the 15q11.2-q13.2 and 15q25.1-q26.1 regions 
showed that the corresponding target area was present in one copy on the derivative chromosome (left). Hybridization with 
BAC probes specific for the 15q26.2-15q26.3 region showed that the corresponding regions were lacking on the derivative 
chromosome (right).Page 5 of 8
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disease, diaphragmatic hernia, eye and face abnormali-
ties, equinovarus, high arched palate, hypertelorism,
hypoplastic kidneys, hypotonia, lung hypoplasia, micro-
cephaly, micrognathia, and spinal cord abnormality.
Although high resolution cytogenetic mapping for all
reported cases are lacking this wide range of phenotypic
manifestations probably reflect size heterogeneity of dis-
tal 15q-deletions. More precise data on 15q-breakpoints
might enable an elucidation of different candidate regions
for different phenotypic manifestations. For instance,
patients suffering from CDH in association with 15q26-
deletion have been extensively studied and a critical
region associated with CDH was assessed to a region rang-
ing from distal 15q26.1 to proximal 15q26.2 [11]. The
15q-breakpoint in the present case mapped outside of the
suggested critical region and in accordance did not suffer
from CDH. Deletions of 15q26 have also been reported in
association with Russel-Silver syndrome, which share
many of the clinical features displayed in patients with
deletions of distal 15q and it is possible that these cases
should be categorized as an subgroup of the latter syn-
drome [24,25].
Table 2: USCS known genes in 93.86–100.30 Mb on chr 15 based on RefSeq, Uniprot annotation, and Genbank mRNA
Gene Uniprot accession number Basepair position on chr 15 Size in basepairs
IGF1R P08069 97010288–97319034 308746
TTC23 Q5W5X9 97494052–97607246 113194
MEF2A Q59GX4 97956185–98071524 115354
ADAMTS17 Q8TE56 98331993–98699650 367657
LINS1 Q9NVQ3 98926957–98959902 32945
ASB7 Q6GSJ6 98960358–99007174 46816
ALDH1A3 Q96GT2 99237584–99274352 36768
LRRK1 Q6NYC0 99276983–99427840 150857
CHSY1 Q86X52 99533455–99609649 76194
SELS Q6GYA4 99628737–99635223 6486
SNRPA1 P09661 99639238–99652983 13745
TM2D3 Q9BRN9 99999572–100010117 10545
TARSL2 Q6B0A1 100011478–100082168 70690
OR4F4 Q96R69 100279868–100280785 917
Array CGHFigure 4
Array CGH. Log2 ratio plot for chromosome 15 displaying the deleted segment (green bar).Page 6 of 8
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the salient finding must be that the majority report loss of
IGFR1, a gene that contributes to a wide range of develop-
mental processes [26]. The relation between IGFR1 and
pre- and postnatal growth in association with distal 15q-
deletions has been studied without conclusive results
[5,8]. In relation to the developmental delay commonly
seen in patients with distal 15q-deletions, the IGF1 recep-
tor gene plays an important function in the development
of the central nervous system, which could partly explain
this feature [27]. Studies on the effect of IGFR1 on the car-
diovascular system indicate that it is an important player
in heart development [24]. Monozygosity of this gene
could therefore partly contribute to the complex cardiac
defects so often seen in patients with this deletion. Obvi-
ously, all suggested clinical features postulated to relate to
loss of one copy of the IGFR gene remains to be eluci-
dated, preferentially by further gene expression studies on
diagnostic material.
MEF2A have been suggested as a candidate gene for the
cardiac defects [11] included in the phenotype of 15q26-
deletions since the gene encode for DNA-binding regula-
tory protein that enhances the differentiation of mesoder-
mal precursor cells to myoblast and therefore is key player
in cardiac myocyte development [28]. The MEF2-family is
an ancient mediator of signal-dependant transcription
and diverse developmental programs and MEF2A was
quite recently demonstrated to be involved in morpho-
genesis of postsynaptic neurons [29] which implicate that
it could also contribute to the developmental delay seen
in the patient.
Another gene in the deleted segment that could be directly
implicated due to its protein function is CHSY1 that
encodes chondroitin sulfate [30], a glycosaminoglycan
expressed on the surface of most cells and in extracellular
matrices. Glycosaminoglycan chains are covalently linked
to a wide range of core protein families and regulate many
biologic processes, including cell proliferation and recog-
nition, extracellular matrix deposition, and morphogene-
sis. Furthermore, TM2D3, located in the deleted region,
synthesizes a protein that have a structural module related
to that of the seven transmembrane domain G protein-
coupled receptor superfamily and may have regulatory
roles in cell death or proliferation signal cascades [31].
Conclusion
We present a case with a dic(15;15)(q11;q26.1) which
was thoroughly characterized with locus specific FISH and
tiling resolution array CGH. The dicentric chromosome
harbor a terminal deletion involving 15q26.2-qter a
region that encompass 14 genes, among which four can-
didate genes could be delineated. MEF2A has previously
been suggested as a candidate gene for the cardiac defects
seen in investigated patients. In addition CHSY1 is
involved in cell proliferation and morphogenesis and
TM2D3 may have regulatory roles in cell death or prolif-
eration signal cascades. Previous studies have demon-
strated that terminal 15q-deletions frequently results in
loss of one allele of the IGF1R gene, a finding also
observed in our patient. IGF1R contributes to a wide range
of developmental processes such as development of the
central nervous and cardiovascular systems, and monozy-
gosity for this gene could contribute to the developmental
delay and complex cardiac defects seen in our patient.
However, all suggested clinical features postulated to
relate to IGF1R deletions remains to be elucidated, prefer-
entially by gene expression studies on patients harboring
similar 15q-aberrations. Hopefully, this may the future
lead to the description of a clear cut clinically recognizable
syndrome.
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